Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Commentary

Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit

Online download statistics by month:

Online download statistics by month: March 2020 to July 2022

	Abstract	Full	Pdf
Mar 2020	541	28	15
Apr 2020	541	18	14
May 2020	146	12	6
Jun 2020	57	4	4
Jul 2020	486	52	38
Aug 2020	145	22	17
Sep 2020	248	25	14
Oct 2020	96	3	1
Nov 2020	83	10	8
Dec 2020	52	5	5
Jan 2021	55	3	3
Feb 2021	40	9	5
Mar 2021	80	10	7
Apr 2021	196	5	6
May 2021	23	4	3
Jun 2021	8	7	7
Jul 2021	7	2	0
Aug 2021	7	3	1
Sep 2021	7	6	3
Oct 2021	43	3	0
Nov 2021	60	2	1
Dec 2021	71	3	3
Jan 2022	65	3	2
Feb 2022	74	0	2
Mar 2022	45	4	2
Apr 2022	42	0	0
May 2022	111	1	0
Jun 2022	62	5	1
Jul 2022	41	2	2
Total	3432	251	170